Cinctive Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Cinctive Capital Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-309,541	Closed	-$5.21M	–	639
2021 Q2	$5.21M	Buy	309,541 +54,352	+21%	+$925K	0.24%	127
2021 Q1	$4.66M	Sell	255,189 -73,856	-22%	-$1.33M	0.29%	142
2020 Q4	$5.99M	Sell	329,045 -2,439	-0.7%	-$42.8K	0.49%	58
2020 Q3	$5.91M	Buy	331,484 +63,800	+24%	+$1.16M	0.52%	57
2020 Q2	$4.8M	Sell	267,684 -826	-0.3%	-$14.8K	0.55%	54
2020 Q1	$4.08M	Sell	268,510 -144,890	-35%	-$2.63M	0.91%	31
2019 Q4	$8.16M	Buy	+413,400	New	+$7.91M	0.85%	24

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cinctive Capital Management's TAK Position: Q3 2021 in Review

Cinctive Capital Management sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 309,541 shares — an estimated $5.21M sold.

Cinctive Capital Management first reported a position in TAK in Q4 2019 and held it in 7 quarters. The position peaked at $8.16M in Q4 2019. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

Cinctive Capital Management reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Cinctive Capital Management sold 309,541 Takeda Pharmaceutical shares in Q3 2021, an estimated $5.21M.
Cinctive Capital Management first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 7 quarters.
Cinctive Capital Management's Takeda Pharmaceutical position peaked at $8.16M in Q4 2019.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.